Edition:
India

Benitec Biopharma ‍Says U.S. FDA Granted Orphan Drug Designation To BB-301​


Monday, 15 Jan 2018 

Jan 15 (Reuters) - Benitec Biopharma Ltd ::‍U.S. FDA HAS GRANTED ORPHAN DRUG DESIGNATION TO BB-301 FOR TREATMENT OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY(OPMD)​. 

Company Quote

5.95
 --
19 Nov 2019